Why Pfizer’s ultra-cold COVID-19 vaccine will not be at the local pharmacy any time soon


  • World
  • Tuesday, 10 Nov 2020

FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/File Photo

NEW YORK (Reuters) - Work to distribute the experimental COVID-19 vaccine developed by Pfizer Inc and BioNTech SE is gearing up after the companies announced successful interim data earlier on Monday, but it will not be coming to local pharmacies for the general public any time soon.

The data, which sent U.S. stocks to record highs [.N], showed that the two companies' experimental vaccine is 90% effective at preventing COVID-19. They are still awaiting data on safety, which could come later this month.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

US will be more isolationist whoever wins election, India foreign minister says
Qatar passes referendum, replaces Shura Council elections with appointments, interior minister says
World Urban Forum participants praise China's efforts to promote urban greening
7 Tunisian students receive Chinese Ambassador Scholarships
Trump wins Indiana and Kentucky, Harris takes Vermont as first polls close in U.S. presidential race
Israeli researchers detect alarming coral bleaching in Red Sea
Austria raises budget deficit forecast for 2024, 2025
Migrant caravan of 3,000 heads north in Mexico as US votes
U.S. stocks close higher
Crude futures settle higher

Others Also Read